AFA designed and facilitated a strategic planning process for senior pharmaceutical executives from different divisions of a global company in the mid-1980s forecasting the rise of managed care and development of outcomes research long before other companies recognized their importance.

AFA produced a forecast of aging and self-care for the U.S., the U.K. and Germany that identified opportunities for growth during a strategic planning retreat of the key worldwide managers of the OTC division of a major European pharmaceutical company.

AFA helped the senior executives of a top global pharma company create a corporate vision statement that has been used successfully throughout the past decade both within the company and in corporate communications to customers.

AFA organized an internal futures workshop for the board and senior management of a European pharmaceutical company, providing expert speakers and forecasts for global health care in the year 2010. Recognizing the value of this workshop, the company enlisted AFA to provide a similar session seven years later.

AFA consulted with an information services and data provider to the pharmaceutical industry, helping develop the vision and strategy that redirected the company into major growth areas. According to the CEO of this company, the vision helped increase sales revenue while it contributed to greater employee job satisfaction and corporate morale.

AFA coached executive teams in ten countries to create scenarios for the international division of a multinational company, providing market forecasts that included China, Japan, Mexico, and South Africa. AFA's networking capabilities also put local teams in touch with local "health futures resources." AFA also helped explore the role of key issues, such as pharmaceutical benefit management in various countries, and to accelerate movement toward the company becoming a "health company."

AFA helped a global consulting firm gain recognition and new business through a series of publications describing emerging developments for the pharmaceutical industry.

AFA provided proprietary scenario workshops and presentations on the future of the pharmaceutical industry to five of the top twenty pharmaceutical companies in 1998 and 1999, as well as to a variety of smaller companies.

AFA futurists provided keynote presentations to strategic sessions held by the Pharmaceutical Research and Manufacturers of America (PhRMA) as well as to senior industry scientists within companies and in industry associations including the Drug Information Association, the American Academy of Pharmaceutical Physicians, and the Regulatory Affairs Professional Society.